Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles
Authors
Keywords
CRISPR/Cas9, Duchenne muscular dystrophy, gene editing, AAV, microdystrophin, dystrophin
Journal
MOLECULAR THERAPY
Volume 29, Issue 3, Pages 1070-1085
Publisher
Elsevier BV
Online
2020-11-06
DOI
10.1016/j.ymthe.2020.11.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
- (2020) Kasia Dzierlega et al. GENE THERAPY
- rAAVrh74.MCK.GALGT2 Protects Against Loss of Hemodynamic Function in the Aging mdx Mouse Heart
- (2019) Rui Xu et al. MOLECULAR THERAPY
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- Development of Novel Micro-dystrophins with Enhanced Functionality
- (2019) Julian N. Ramos et al. MOLECULAR THERAPY
- In Situ Modification of Tissue Stem and Progenitor Cell Genomes
- (2019) Jill M. Goldstein et al. Cell Reports
- AAV-based gene therapies for the muscular dystrophies
- (2019) Julie M Crudele et al. HUMAN MOLECULAR GENETICS
- High levels of AAV vector integration into CRISPR-induced DNA breaks
- (2019) Killian S. Hanlon et al. Nature Communications
- CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
- (2018) Benjamin L. Duchêne et al. MOLECULAR THERAPY
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
- (2018) Tahnee L. Kennedy et al. Molecular Therapy-Methods & Clinical Development
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
- (2017) Niclas E. Bengtsson et al. Nature Communications
- Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles
- (2016) Cécile Peccate et al. HUMAN MOLECULAR GENETICS
- Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
- (2016) Jean-Paul Iyombe-Engembe et al. Molecular Therapy-Nucleic Acids
- Progress and prospects of gene therapy clinical trials for the muscular dystrophies
- (2015) Niclas E. Bengtsson et al. HUMAN MOLECULAR GENETICS
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
- (2015) William Duddy et al. Skeletal Muscle
- Adeno-associated viral vectors do not efficiently target muscle satellite cells
- (2014) Andrea LH Arnett et al. Molecular Therapy-Methods & Clinical Development
- Evidence-based path to newborn screening for duchenne muscular dystrophy
- (2012) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins
- (2010) Glen B. Banks et al. PLoS Genetics
- DIAPHRAGM MUSCLE STRIP PREPARATION FOR EVALUATION OF GENE THERAPIES IN mdx MICE
- (2008) John A Faulkner et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient Mice
- (2008) Guy L Odom et al. MOLECULAR THERAPY
- Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice
- (2008) Paul Gregorevic et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started